Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name Silenseed Ltd Proposed Ticker RNAI CUSIP N/A Business Description An emerging biopharmaceutical company discovering and developing proprietary RNA interference (RNAi)-based cancer drugs and delivery systems designed to effectively penetrate and treat malignant solid tumors. Lead Underwriter Aegis Capital Corp Co-Managers N/A Initial Shares N/A Revised Initial Shares N/A Initial Price N/A Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.